Pyramid Labs
A Reliable CDMO Partner for Injectable drug products. From Development to Commercial Manufacturing.
A Reliable CDMO Partner for Injectable drug products. From Development to Commercial Manufacturing.
Pyramid Labs is a long-standing CDMO (Contract Development and Manufacturing Organization) specializing in the development and manufacturing of injectable drug products. Established in 1988, the company's extensive range of capabilities includes clinical and commercial vial & syringe fill/finish, lyophilization, liquid and lyophilized drug product formulation, quality control laboratory services, and analytical method development & validation. Pyramid Labs is committed to providing reliable services to pharmaceutical companies seeking a dependable partner for their drug product development and commercial manufacturing needs. The company, headquartered in the United States, recently attracted a Private Equity Round investment on 18th April 2023. The investment was secured from Audax Private Equity, highlighting investor confidence in the potential and growth prospects of Pyramid Labs. With a strong focus on the manufacturing industry, Pyramid Labs continues to demonstrate its expertise and market relevance as a leading CDMO partner for injectable drug products.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 1 |
|
18 Apr 2023 |
No recent news or press coverage available for Pyramid Labs.
We care about your data, and we'd love to use cookies make your experience better.
